Wilks; Andrew Frederick
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wilks; Andrew Frederick.The latest application filed is for "phenyl amino pyrimidine compounds and uses thereof".
Company Profile
0.23.30
- Wilks; Andrew Frederick - South Yarra AU
- Wilks; Andrew Frederick - Richmond AU
- Wilks; Andrew Frederick - Victoria AU
- Wilks; Andrew Frederick - Doneaster East AU
Patent Activity
| Patent | Date |
|---|---|
| Phenyl Amino Pyrimidine Compounds And Uses Thereof App 20210309615 - Burns; Christopher John ; et al. | 2021-10-07 |
| Substituted 1,2,4-triazines as tubulin inhibitors Grant 9,732,046 - Burns , et al. August 15, 2 | 2017-08-15 |
| Methods For Inhibiting Necroptosis App 20170114025 - Lucet; Isabelle ; et al. | 2017-04-27 |
| Tubulin Inhibitors App 20160031835 - Burns; Christopher John ; et al. | 2016-02-04 |
| Phenyl amino pyrimidine compounds and uses thereof Grant 9,238,628 - Burns , et al. January 19, 2 | 2016-01-19 |
| Phenyl amino pyrimidine compounds and uses thereof Grant 9,233,934 - Burns , et al. January 12, 2 | 2016-01-12 |
| Substituted pyrazines as tubulin inhibitors Grant 9,139,560 - Burns , et al. September 22, 2 | 2015-09-22 |
| Tubulin Inhibitors App 20140221396 - BURNS; Christopher John ; et al. | 2014-08-07 |
| Phenyl Amino Pyrimidine Compounds And Uses Thereof App 20140011803 - BURNS; Christopher John ; et al. | 2014-01-09 |
| Phenyl Amino Pyrimidine Compounds And Uses Thereof App 20140005180 - BURNS; Christopher John ; et al. | 2014-01-02 |
| Tubulin Inhibitors App 20130274263 - Burns; Christopher John ; et al. | 2013-10-17 |
| Phenyl amino pyrimidine compounds and uses thereof Grant 8,486,941 - Burns , et al. July 16, 2 | 2013-07-16 |
| 2-phenyl pyrazines as tubulin inhibitors Grant 8,394,806 - Burns , et al. March 12, 2 | 2013-03-12 |
| Benzimidazoles as selective kinase inhibitors Grant 8,329,737 - Styles , et al. December 11, 2 | 2012-12-11 |
| Pyrazine-based tubulin inhibitors Grant 8,084,456 - Burns , et al. December 27, 2 | 2011-12-27 |
| Tubulin Inhibitors App 20110269760 - Burns; Christopher John ; et al. | 2011-11-03 |
| 2-phenyl pyrimidines which are tubulin inhibitors Grant 7,981,900 - Burns , et al. July 19, 2 | 2011-07-19 |
| Selective Kinase Inhibitors App 20110082142 - STYLES; MICHELLE LEANNE ; et al. | 2011-04-07 |
| Peptide that inhibits janus kinase Grant 7,795,206 - Wilks , et al. September 14, 2 | 2010-09-14 |
| Phenyl Amino Pyrimidine Compounds And Uses Thereof App 20100197671 - Burns; Christopher John ; et al. | 2010-08-05 |
| Substituted pyrazines as kinase inhibitors Grant 7,737,143 - Burns , et al. June 15, 2 | 2010-06-15 |
| Kinase inhibitors Grant 7,598,272 - Burns , et al. October 6, 2 | 2009-10-06 |
| Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof Grant 7,593,820 - Wilks , et al. September 22, 2 | 2009-09-22 |
| Kinase inhibitors Grant 7,511,047 - Burns , et al. March 31, 2 | 2009-03-31 |
| Selective Kinase Inhibitors App 20080207613 - Styles; Michelle Leanne ; et al. | 2008-08-28 |
| Tubulin Inhibitors App 20080194583 - Burns; Christopher John ; et al. | 2008-08-14 |
| Crystal structure and uses thereof App 20070276607 - Wilks; Andrew Frederick ; et al. | 2007-11-29 |
| Kinase inhibitors Grant 7,259,179 - Burns , et al. August 21, 2 | 2007-08-21 |
| Kinase inhibitors App 20070161635 - Burns; Christopher John ; et al. | 2007-07-12 |
| Crystal structure and uses thereof App 20070136005 - Wilks; Andrew Frederick ; et al. | 2007-06-14 |
| Crystal structure and uses thereof App 20070136006 - Wilks; Andrew Frederick ; et al. | 2007-06-14 |
| Crystal structure and uses thereof App 20070129895 - Wilks; Andrew Frederick ; et al. | 2007-06-07 |
| Crystal structure and uses thereof App 20070129896 - Wilks; Andrew Frederick ; et al. | 2007-06-07 |
| Crystal structure and uses thereof App 20070128709 - Wilks; Andrew Frederick ; et al. | 2007-06-07 |
| Azole-based kinase inhibitors App 20070099935 - Burns; Christopher John ; et al. | 2007-05-03 |
| Pyrazine-based tubulin inhibitors App 20070082894 - Burns; Christopher John ; et al. | 2007-04-12 |
| Protein kinase signalling App 20070032411 - Wilks; Andrew Frederick ; et al. | 2007-02-08 |
| Kinase inhibitors App 20060270687 - Burns; Christopher John ; et al. | 2006-11-30 |
| Kinase inhibitors App 20060241112 - Burns; Christopher John ; et al. | 2006-10-26 |
| Protein kinase inhibitors Grant 7,122,550 - Burns , et al. October 17, 2 | 2006-10-17 |
| Protein kinase inhibitors App 20060148824 - Burns; Christopher John ; et al. | 2006-07-06 |
| Methods of inhibiting kinases App 20060069084 - Burns; Christopher John ; et al. | 2006-03-30 |
| Kinase inhibitors App 20050004140 - Burns, Christopher John ; et al. | 2005-01-06 |
| Protein kinase inhibitors App 20040235862 - Burns, Christopher John ; et al. | 2004-11-25 |
| Protein kinase signalling App 20040142404 - Wilks, Andrew Frederick ; et al. | 2004-07-22 |
| Method of inhibiting kinases App 20040102455 - Burns, Christopher John ; et al. | 2004-05-27 |
| Protein tyrosine kinase Grant 5,910,426 - Wilks , et al. June 8, 1 | 1999-06-08 |
| Protein tyrosine kinase Grant 5,852,184 - Wilks , et al. December 22, 1 | 1998-12-22 |
| Method for determining tyrosine kinase in a sample Grant 5,821,069 - Wilks , et al. October 13, 1 | 1998-10-13 |
| Protein tyrosine kinase Grant 5,716,818 - Wilks , et al. February 10, 1 | 1998-02-10 |
| Antibodies which specifically bind to proteins having tyrosine kinase activity, wherein said proteins have more than one tyrosine kinase domain, and no SH2 domains Grant 5,658,791 - Wilks , et al. August 19, 1 | 1997-08-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 